Pathos AI
Senior Computational Biologist, Oncology
New York City, NY · Senior
Sponsorship not specifiedDetected 193 days ago
PythonData ScienceAgentic AIClinical TrialsBioinformaticsAnimal StudiesLeadershipCollaboration
About the role
- We are redefining how oncology drug development is done: integrated, data-driven, and built from first principles.
- As a Senior Computational Biologist, you will sit at the intersection of genomics, translational science, and clinical development.
- Your work will span discovery through Phase 1/2 clinical trials, with direct impact on indication selection, dose expansion strategy, and Go/No-Go decisions.
Responsibilities
- Design, build, and maintain end-to-end translational genomics pipelines supporting oncology drug programs, including RNA-seq, DNA (SNV/CNV/structural variants), and multi-omic integration.
- Partner closely with clinical, translational, and regulatory teams to: Define biomarker strategies for trial protocols Support dose escalation/expansion decisions Inform indication prioritization and patient enrichment strategies Translate multimodal model outputs and large-scale genomic analyses into clear, defensible recommendations for development teams and leadership.
- Pathos is building a next-generation biotech with AI at the core.
- We're building the largest foundation model in oncology and pairing it with proprietary AI systems, deep oncology expertise, and 200+ petabytes of multimodal data linked to patient outcomes, so we can make development decisions with more precision, much earlier.
- We're well-capitalized and have the leadership to build a generational company.
Requirements
- 5+ years' experience in a pharma or biotech company supporting oncology drug development in a translational, biomarker, or early clinical (Phase 1/2) setting.
- Technical & Domain Expertise Deep expertise in cancer genomics and transcriptomics, including hands-on experience with RNA-seq and DNA variant analysis in clinical contexts.
- Strong understanding of translational biomarkers across the drug development lifecycle, from hypothesis generation to clinical readouts.
- Experience analyzing biomarker data from interventional clinical trials, including response modeling, survival analysis, and subgroup discovery.
- Demonstrated ability to integrate genomic data with clinical endpoints and operational trial data.
- Familiarity with large oncology datasets (e.g., Tempus, TCGA, AACR GENIE) and applying them to inform development strategy.
- Who you are Training PhD (or equivalent industry experience) in computational biology, cancer genomics, bioinformatics, or a related field.
Benefits
- They fail because they were tested in the wrong patients, with the wrong assumptions, in trials that couldn't answer the real question: who benefits, and why?
Company info
- We invest in and advance our own clinical-stage programs, using our AI platform to sharpen trial design, patient selection and biomarker strategy.
Apply directly at Pathos AI →Create a free account for alerts like thisView Pathos AI immigration profile
This listing is sourced directly from Pathos AI's careers page and normalized into a canonical job model.